Data challenges hinder machine learning in drug development
While machine learning has the potential to identify new treatments, reduce failure rates in clinical trials and improve drug development, a lack of high-quality data is hindering the use of the technology.
A laboratory specialist uses a microscope to check cells during the last phase of vaccine manufacture inside a clean laboratory at the Sotio AS biotechnology company in Prague, Czech Republic, on Wednesday, July 20, 2016. Czech Republics richest man, billionaire Petr Kellner’s Sotio biotech company, which is seeking to develop active cellular immunotherapy for treatment […]
More for you
See AllLoading data for hdm_tax_topic #better-outcomes...